IMUGENE CHART. TA only, page-26076

First 26076 Last

Share
Profile

Follow
godiva

1,536 Posts.

403

08/11/23

08:34

Post #: 70777381
Share

Originally posted by Eaglenebula: ↑

Hi
CR implies there is no visible disease on a scan. It is not exactly the same as a cure. People can have a CR and then have the disease come back again. There could be a small amount of residual disease that is below the ability of the scan to detect it. It could also be completely resolved. Time will tell. That patient will have more scans. It is very unlikely to be due to other factors. It is impossible to know what proportion of patients will have a CR until they run the full trial as the numbers are too small in this preliminary trial.

The other results are also great. You can imagine having your cancer partially go away or not get worse would be greatly appreciated in someone who has exhausted all other treatment options. Some of these patients could go on to have a CR or may have a significant period where the disease does not progress. Even small gains in this setting are helpful. An average increase in survival of a few months is considered a good result. Particularly in this setting. This would be appreciated by doctors and patients and be useful clinically.

As imu are claiming it is an impressive early result in a group of cancers that are the hardest to treat and with varying treatment doses which have not yet been optimized. Exactly how good we won’t know until the full trials are run but there is plenty of reason for optimism.

Expand

Not maximum dose as well, so results could have been even
better with higher.

IMU Price at posting: 6.6¢ Sentiment: Buy Disclosure: Held
5 Upvote

0 Great analysis

Reply

Top Stories

With financials holding the fort, materials must step up with some heavy lifting to stimulate stocks

AML

Cultural heritage agreement puts Walford Creek exploration back on the map

RDN

If you thought lithium was dead, think again. The Pilbara will be central to the next upswing

STX

Strike Energy secures $153 million for Perth Basin gas projects

SBW

Shekel Brainweigh CEO Nir Leshem weighs in on AI adoption ahead of FY25

There are more pages in this discussion • 7,046 more messages in this thread...

First 26076 Last

Add IMU (ASX) to my watchlist

(20min delay)
Last 5.5¢		Change -0.004(6.78%)		Mkt cap ! $402.5M

Open	High	Low	Value	Volume
6.0¢	6.1¢	5.5¢	$2.515M	44.29M

Buyers (Bids)

No.	Vol.	Price($)
12	819340	5.5¢

Sellers (Offers)

Price($)	Vol.	No.
5.6¢	515951	4

View Market Depth

No.	Vol.	Price($)
10	736340	0.055
29	2959163	0.054
17	1584508	0.053
19	1719511	0.052
22	3589607	0.051

Price($)	Vol.	No.
0.056	515951	4
0.057	1117035	10
0.058	1866575	10
0.059	2264940	6
0.060	1912026	16

Last trade - 16.10pm 24/06/2024 (20 minute delay)

IMU (ASX) Chart

IMUGENE CHART. TA only, page-26076

With financials holding the fort, materials must step up with some heavy lifting to stimulate stocks

Cultural heritage agreement puts Walford Creek exploration back on the map

If you thought lithium was dead, think again. The Pilbara will be central to the next upswing

Strike Energy secures $153 million for Perth Basin gas projects

Shekel Brainweigh CEO Nir Leshem weighs in on AI adoption ahead of FY25

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

IMUGENE CHART. TA only, page-26076

Top Stories

With financials holding the fort, materials must step up with some heavy lifting to stimulate stocks

Cultural heritage agreement puts Walford Creek exploration back on the map

If you thought lithium was dead, think again. The Pilbara will be central to the next upswing

Strike Energy secures $153 million for Perth Basin gas projects

Shekel Brainweigh CEO Nir Leshem weighs in on AI adoption ahead of FY25

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News